imageResearch & Discovery

A Blog Devoted to UD Innovation, Excellence and Scholarship
image

Research & Discovery

A Blog Devoted to UD Innovation, Excellence and Scholarship

Manufacturing USA headquarters

by | December 16, 2016

ABOVE: Secretary of Commerce Penny Pritzker announces the National Institute for Innovation in Manufacturing Biopharmaceuticals. | Photo by Evan Krape

Secretary of Commerce visits UD to announce new institute

Secretary of Commerce Penny Pritzker visited the University of Delaware today, where she announced a new institute to advance U.S. leadership in pharmaceutical manufacturing.

The Newark-based National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) will be the 11th Manufacturing USA Institute.

Biopharmaceuticals are prescription drugs made with living cells. Most drugs are chemistry-based and far easier to produce. The biopharmaceutical category includes vaccines, cancer drugs and drugs to treat autoimmune diseases, as well as emerging drugs for cell and gene therapies.

The institute will focus on bringing safe drugs to market faster and on developing workforce training. The biopharmaceutical field has a negative unemployment rate, with more jobs available than there are qualified workers.

A team of more than 150 companies, educational institutions, nonprofits and state governments will operate NIIMBL under a newly formed nonprofit.

Expected total investment from all stakeholders totals $250 million, including $70 million of federal investment.

The University of Delaware will handle administrative duties for the institute in partnership with the Commerce Department’s National Institute of Standards and Technology (NIST). Its headquarters will be on UD’s campus in a location to be determined.

UD Research on Twitter

TOP STORIES

speakers biopharmaceutical symposium

Leading the Way in Biopharmaceuticals

Thought leaders explore emerging area of biotherapeutics

NIIMBL

A NIIMBL Approach To Making Modern Medicines

Biopharmaceuticals have emerged recently and are having a revolutionary impact on vexing diseases such as cancer. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making medicines more accessible to Americans.

UD Women of Research

Women of Research

Extraordinary research is underway at the University of Delaware, and women are all over it. We profile seven researchers who offer insight into their work—from coral reefs to corporations—what hurdles they have cleared and what keeps them moving forward.

Share This